The AMF has announced that the simplified tender offer for Biocorp shares filed by Portzamparc (BNP Paribas group) and Lazard Frères Banque, acting on behalf of Novo Nordisk, will be open from September 7 to 27 inclusive.

As a reminder, the Danish pharmaceutical company has irrevocably undertaken to acquire, at a unit price of 35 euros, all the 1,094,726 shares it does not already own, representing 24.81% of the company's capital and 24.72% of its voting rights.094,726 shares it does not hold, representing 24.81% of the share capital and 24.72% of the voting rights of this company.

It intends to request, at the end of the offer period, and if the required conditions are met, the implementation of a squeeze-out for Biocorp shares not tendered to the offer, at the same price.

Copyright (c) 2023 CercleFinance.com. All rights reserved.